Emergency department evaluation and treatment of patients with ST-segment elevation myocardial infarction

Critical Pathways in Cardiology

Volumn 3, Issue 3, 2004, Pages 110-113

  Aghababian, Richard V ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Department of Emergency Medicine ^*  (United States)

Author keywords

ACS differential diagnosis; ED management of STEMI; Initial evaluation of STEMI patients; Symptoms of STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; COCAINE; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NITRATE; RECOMBINANT PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I; TROPONIN T;

ACUTE DISEASE; ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART CATHETER; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; LABORATORY TEST; OXYGEN THERAPY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT; ST SEGMENT ELEVATION; THORAX RADIOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

EID: 4644335414     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000139587.97781.ca     Document Type: Conference Paper

References (18)

1. 2002 Heart and Stroke Statistical Update. American Heart Association; 2001. Available at http://www.americanheart.org.
2. Mosca L, Jones WK, King KB, et al. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000;9:506-515.
3. 2002 Heart and Stroke Statistical Update. American Heart Association; 2001.
4. National Center for Health Statistics; 2001.
5. Furman MI, Dauerman HL, Goldberg RJ, et al. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001;37:1571-1580.
6. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-580.
7. Kannel A. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertension Res. 1995;18:181-196.
8. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med. 1992;117:10-17.
9. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
10. American Heart Association. Circulation. 2002;106:1893-1900.
11. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
12. Anderson HR, et al. N Engl J Med. 2003;349:733-742.
13. Grzyabowski, et al. JAMA. 2003;290:1891-1898.
14. Jacobs AK. Primary angioplasty for acute myocardial infarction - is it worth the wait? N Engl J Med. 2003;349:798-800.
15. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231.
16. Topol EJ, GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001;357:1905-1914.
17. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483-1488.
18. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269-1276.